Key facts
- This page summarizes EcoR1 Capital, LLC's Form 4 filing for ANAPTYSBIO, INC (ANAB).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Nov 2026, 18:56.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
Purchase
Purchase
Purchase
Purchase
Additional SEC filing notes
Footnote F1
The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interests therein.
Footnote F2
Qualified Funds did not purchase any of the securities in this transaction.
Footnote F3
Qualified Fund purchased 113,048 of the shares in this transaction.
Footnote F4
After this transaction, Qualified Fund held 7,515,020 shares of the Issuer's Common Stock
Footnote F5
Qualified Fund purchased 127,917 of the shares in this transaction.
Footnote F6
After this transaction, Qualified Fund held 7,642,937 shares of the Issuer's Common Stock.